Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Will Moderna-NIH Patent Dispute Change Government-Industry Collaborations?

Nov 16 2021

• By Brenda Sandburg

Vaccine card — Moderna claims NIH is not co-inventor of a component of its COVID-19 vaccine • Source: Alamy

Related Content

Gilead's PrEP Research Deal With CDC Is Factor In Outcome Of HIV Patent Suit

Feb 07 2020

HIV PrEP Patent Dispute Escalates As HHS Files Suit Against Gilead

Nov 08 2019

Coronavirus Update: US To Begin Mass Vaccinations After Pfizer’s Historic Emergency Authorization

Dec 12 2020

Coronavirus Update: Inside Moderna's Deal With The US

Aug 19 2020

Coronavirus Update: BARDA Funding Rises To $955m As Moderna Expands Phase III Trial

Jul 27 2020

BARR LABS GRANTED NONEXCLUSIVE AZT LICENSE BY NIH

Jul 22 1991

Related Companies

Moderna, Inc.

Burroughs Wellcome Co.

Gilead Sciences, Inc.

Additional Topics

United States Coronavirus COVID-19 Intellectual Property Vaccines Legal Issues Policy BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window